Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Brunn

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|February 1, 1977
Thymus-derived lymphocytes in the Vogt-Koyanagi-Harada syndromeD H Char, J Brunn, W West
FEBS Letters|July 15, 1999
Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTORD Yang, G J Brunn, J C Lawrence
Circulation Research|March 4, 2006
Differential regulation of endothelial cell activation by complement and interleukin 1alphaGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Circulation Research|February 23, 2008
Constitutive repression of interleukin-1alpha in endothelial cellsGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Discovery Medicine|January 20, 2007
Toward a modern concept of sepsis: new answers to ancient questionsGregory J Brunn, Marilou F Wijdicks, Jeffrey L Platt
Critical Reviews in Immunology|August 9, 2003
Activation of mammalian Toll-like receptors by endogenous agonistsGeoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Trends in Biochemical Sciences|August 1, 2000
Heparanase, a potential regulator of cell-matrix interactionsL A Dempsey, G J Brunn, J L Platt
Journal of Leukocyte Biology|May 15, 2007
Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditionsAmy H Tang, Gregory J Brunn, Marilia Cascalho, et al.
The Journal of Biological Chemistry|January 24, 1998
The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminusG J Brunn, P Fadden, T A Haystead, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|February 1, 1977
Thymus-derived lymphocytes in the Vogt-Koyanagi-Harada syndromeD H Char, J Brunn, W West
FEBS Letters|July 15, 1999
Mutational analysis of sites in the translational regulator, PHAS-I, that are selectively phosphorylated by mTORD Yang, G J Brunn, J C Lawrence
Circulation Research|March 4, 2006
Differential regulation of endothelial cell activation by complement and interleukin 1alphaGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Circulation Research|February 23, 2008
Constitutive repression of interleukin-1alpha in endothelial cellsGregory J Brunn, Soheyla Saadi, Jeffrey L Platt
Discovery Medicine|January 20, 2007
Toward a modern concept of sepsis: new answers to ancient questionsGregory J Brunn, Marilou F Wijdicks, Jeffrey L Platt
Critical Reviews in Immunology|August 9, 2003
Activation of mammalian Toll-like receptors by endogenous agonistsGeoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4Geoffrey B Johnson, Gregory J Brunn, Jeffrey L Platt
Trends in Biochemical Sciences|August 1, 2000
Heparanase, a potential regulator of cell-matrix interactionsL A Dempsey, G J Brunn, J L Platt
Journal of Leukocyte Biology|May 15, 2007
Pivotal advance: endogenous pathway to SIRS, sepsis, and related conditionsAmy H Tang, Gregory J Brunn, Marilia Cascalho, et al.
The Journal of Biological Chemistry|January 24, 1998
The mammalian target of rapamycin phosphorylates sites having a (Ser/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminusG J Brunn, P Fadden, T A Haystead, et al.
Pageof 7